Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Kaposi Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00474994
What this trial is testing

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

Who this might be right for
Adult Malignant Fibrous Histiocytoma of BoneDesmoid TumorEndometrial Cancer+3 more
Memorial Sloan Kettering Cancer Center 53
Early research (Phase 1)Ended earlyNCT02408861
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmAnal CarcinomaHIV Infection+7 more
National Cancer Institute (NCI) 79
Testing effectiveness (Phase 2)WithdrawnNCT02137564
What this trial is testing

Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma

Who this might be right for
AIDS-related Kaposi SarcomaHIV InfectionRecurrent Kaposi Sarcoma
AIDS Malignancy Consortium
Testing effectiveness (Phase 2)Study completedNCT00051597
What this trial is testing

A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies

Who this might be right for
Hodgkin DiseaseLymphoma, Large-CellSarcoma, Kaposi+2 more
Seagen Inc. 70
Early research (Phase 1)Ended earlyNCT00427414
What this trial is testing

Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
AIDS Malignancy Consortium 14
Testing effectiveness (Phase 2)Study completedNCT00003657
What this trial is testing

High-dose ICE With Amifostine

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more
Dana-Farber Cancer Institute 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03038672
What this trial is testing

Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas

Who this might be right for
ALK-Positive Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Activated B-Cell TypeDiffuse Large B-Cell Lymphoma Associated With Chronic Inflammation+32 more
National Cancer Institute (NCI) 54
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT01057121
What this trial is testing

Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma

Who this might be right for
AIDS-Related Kaposi SarcomaRecurrent Kaposi Sarcoma
National Cancer Institute (NCI) 38
Not applicableStudy completedNCT00075777
What this trial is testing

Valproic Acid in Treating Patients With Kaposi's Sarcoma

Who this might be right for
Sarcoma
AIDS Malignancy Consortium 19
Testing effectiveness (Phase 2)Study completedNCT00019188
What this trial is testing

Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Epidemic Kaposi's SarcomaRecurrent Kaposi's Sarcoma
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00002936
What this trial is testing

Altretamine and Etoposide in Treating Patients With HIV-Related Cancer

Who this might be right for
LymphomaSarcoma
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT00686842
What this trial is testing

PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

Who this might be right for
Kaposi's Sarcoma
AIDS Malignancy Consortium 17
Testing effectiveness (Phase 2)Study completedNCT00090987
What this trial is testing

Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
AIDS Malignancy Consortium 30
Not applicableLooking for participantsNCT05663502
What this trial is testing

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Who this might be right for
Anal CarcinomaHematopoietic and Lymphoid Cell NeoplasmHIV Infection+9 more
AIDS Malignancy Consortium 200
Testing effectiveness (Phase 2)Study completedNCT00005042
What this trial is testing

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
AIDS Malignancy Consortium
Testing effectiveness (Phase 2)Study completedNCT01154452
What this trial is testing

Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma

Who this might be right for
Adult Alveolar Soft Part SarcomaAdult AngiosarcomaAdult Desmoplastic Small Round Cell Tumor+32 more
National Cancer Institute (NCI) 78